{{Rsnum
|rsid=6929846
|Gene=BTN2A1
|Chromosome=6
|position=26458037
|Orientation=plus
|GMAF=0.247
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=BTN2A1
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 69.0 | 29.2 | 1.8
| HCB | 80.7 | 18.5 | 0.7
| JPT | 84.1 | 15.0 | 0.9
| YRI | 23.8 | 46.9 | 29.3
| ASW | 26.3 | 43.9 | 29.8
| CHB | 80.7 | 18.5 | 0.7
| CHD | 90.8 | 8.3 | 0.9
| GIH | 60.4 | 35.6 | 4.0
| LWK | 19.1 | 54.5 | 26.4
| MEX | 37.9 | 53.4 | 8.6
| MKK | 23.7 | 45.5 | 30.8
| TSI | 61.8 | 34.3 | 3.9
| HapMapRevision=28
}}{{PMID Auto
|PMID=21211798
|Title=Association of a polymorphism of BTN2A1 with myocardial infarction in East Asian populations
}}

{{PMID Auto
|PMID=21525964
|Title=Association of a Polymorphism of BTN2A1 With Hypertension in Japanese Individuals
}}

{{PMID Auto
|PMID=21468600
|Title=Association of polymorphisms of BTN2A1 and ILF3 with myocardial infarction in Japanese individuals with different lipid profiles
}}

{{PMID Auto
|PMID=21347509
|Title=Association of polymorphisms of BTN2A1 and ILF3 with myocardial infarction in Japanese individuals with or without hypertension, diabetes mellitus or chronic kidney disease.
}}

{{PMID Auto
|PMID=21557786
|Title=Association of a genetic variant of BTN2A1 with chronic kidney disease in Japanese individuals.
}}

{{PMID Auto
|PMID=21672009
|Title=Association of a polymorphism of BTN2A1 with type 2 diabetes mellitus in Japanese individuals.
}}

{{PMID Auto
|PMID=21784758
|Title=Association of a genetic variant of BTN2A1 with metabolic syndrome in East Asian populations.
}}

{{PMID Auto
|PMID=22576629
|Title=Synergistic effects of genetic variants of APOA5 and BTN2A1 on dyslipidemia or metabolic syndrome.
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}